NextCure, Inc.
NXTC
$8.21
-$0.07-0.85%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -18.13% | -18.85% | -19.25% | -17.60% | -16.50% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -39.21% | 5.72% | 0.72% | -0.37% | 0.31% |
| Operating Income | 39.21% | -5.72% | -0.72% | 0.37% | -0.31% |
| Income Before Tax | 29.84% | -10.38% | -0.34% | 0.87% | 0.57% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 29.84% | -10.38% | -0.34% | 0.87% | 0.57% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 29.84% | -10.38% | -0.34% | 0.87% | 0.57% |
| EBIT | 39.21% | -5.72% | -0.72% | 0.37% | -0.31% |
| EBITDA | 38.94% | -7.84% | -2.01% | -0.51% | -1.32% |
| EPS Basic | 60.38% | 11.69% | 9.64% | 3.78% | 1.66% |
| Normalized Basic EPS | 64.07% | 11.69% | 5.30% | -0.59% | -2.59% |
| EPS Diluted | 60.38% | 11.69% | 9.64% | 3.78% | 1.66% |
| Normalized Diluted EPS | 64.07% | 11.69% | 5.30% | -0.59% | -2.59% |
| Average Basic Shares Outstanding | 83.56% | 52.96% | 21.93% | 4.36% | 0.78% |
| Average Diluted Shares Outstanding | 83.56% | 52.96% | 21.93% | 4.36% | 0.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |